Androgen receptor levels in prostate cancer epithelial and peritumoral stromal cells identify non-organ confined disease

Abstract

These findings suggest that AR is an important determinant of disease relapse in early stage prostate cancer, and that altered AR levels in the malignant epithelial cells or in the peritumoral stroma is indicative of non-organ confined prostate cancer.